FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $129,000 | +1742.9% | 3,415 | +94.8% | 0.00% | – |
| Q3 2019 | $7,000 | -36.4% | 1,753 | 0.0% | 0.00% | – |
| Q2 2019 | $11,000 | -52.2% | 1,753 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | +43.8% | 1,753 | 0.0% | 0.00% | – |
| Q4 2018 | $16,000 | -33.3% | 1,753 | 0.0% | 0.00% | – |
| Q3 2018 | $24,000 | -14.3% | 1,753 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | -6.7% | 1,753 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | -21.1% | 1,753 | 0.0% | 0.00% | – |
| Q4 2017 | $38,000 | +31.0% | 1,753 | +144.8% | 0.00% | – |
| Q3 2017 | $29,000 | -77.7% | 716 | -83.4% | 0.00% | -100.0% |
| Q2 2017 | $130,000 | -82.0% | 4,315 | -78.5% | 0.00% | -85.7% |
| Q1 2017 | $724,000 | -22.8% | 20,030 | +7.0% | 0.01% | -30.0% |
| Q4 2016 | $938,000 | -81.6% | 18,728 | -80.7% | 0.01% | -81.1% |
| Q3 2016 | $5,092,000 | +55.4% | 97,015 | +22.4% | 0.05% | +23.3% |
| Q2 2016 | $3,277,000 | +7.9% | 79,245 | +6.1% | 0.04% | +13.2% |
| Q1 2016 | $3,036,000 | +65.9% | 74,714 | +69.5% | 0.04% | +65.2% |
| Q4 2015 | $1,830,000 | +183.7% | 44,089 | +5.2% | 0.02% | +155.6% |
| Q3 2015 | $645,000 | – | 41,914 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|